Regeneron Gets the ‘Ultimate Validation’ After Trump’s Treatment

(Bloomberg) -- Regeneron Pharmaceuticals Inc. climbed the most in almost seven months on Monday after U.S. President Donald Trump received the biotech company’s antibody cocktail to treat Covid-19.